Multi-MeMo stands for “Shorter- and longer-term mechanisms of multimodal interventions to prevent dementia”. Funded by JPND, the project aligns experimental molecular, cellular, and animal models with a very strong array of unique multi-national multimodal human trials which have already demonstrated multi-year cognitive and functional benefits across the entire continuum from at-risk to prodromal disease stages. This will allow comprehensive in-depth analysis of multiple relevant molecular and cellular mechanisms that cannot be clarified from human trials alone, as well as to rapidly validate the identified mechanisms for clinical relevance using successful long-term (up to 11years) human trial data and samples.

Multi-MeMo is an EU Joint Programme – Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND – Finland, Research Council of Finland; Germany, Federal Ministry of Education and Research; Luxembourg, National Research Fund; Netherlands, The Netherlands Organisation for Health Research and Development; Slovakia, Ministry of Education, Science, Research and Sport of the Slovak Republic; Spain, National Institute of Health Carlos III.

Representatives of Alzheimer Europe involved in the project:

Cindy supports the communication and dissemination work of Multi-MeMo.
Alzheimer Europe Staff - Project Officer - Ana Dia
Ana participates in the Public Involvement work of the project.
Portrait of  Sarah Campill, Alzheimer Europe Public Invlvement Officer
Sarah supports the Public Involvement work of the project.